Effective December 11th, 2019, Spectrum Health Regional Laboratory’s Immunochemistry laboratory will be upgrading the following tests from the Immunoassay Vidas platform to the Multiplex flow immunoassay Bioplex 2200 platform.
Cytomegalovirus IgG Antibody
Cytomegalovirus IgM Antibody
Toxoplasma IgG Antibody
Toxoplasma IgM Antibody
Lyme Total Antibody
All tests will continue to have the same collection instructions, processing instructions, rejection criteria, specimen stability, turn-around-time, and qualitative reference ranges of negative. Continue Reading
As of November 25th 2019 the following tests for Herpes Simplex Virus (HSV) IgM antibody testing will be obsoleted.
Herpes IgM Antibody Screen – LAB3576
Herpes Simplex Virus (HSV) Antibody Screen, IgM, by EIA, Serum – LAB3578
Herpes Simplex Panel – LAB1230539 Continue Reading
Effective immediately, Carboxyhemoglobin testing is now limited to hospital sites only. Due to a recall on the BD tubes, this test must now be drawn in a pre-heparinized blood gas syringe or pre-heparinized capillary tube. Please refer to the lab catalog for collection information. Continue Reading
The Spectrum Health Regional Laboratory Hematology Department has updated rejection criteria for the orderables, Cell Count w/ Differential, Body Fluid and Cell Count, Body Fluid. Spectrum Health Hematology will no longer perform cell counts on specimens which are not from a sterile body cavity (e.g. wound drainage, abscess, pus, etc.). Unacceptable specimens submitted to the Hematology Department for cell counts will not be performed and the test will be credited. Continue Reading
The treatment of non-small cell lung adenocarcinoma has become more successful due to targeted treatments based on the molecular profile of a patient’s particular tumor. The Lung Cancer Mutation Analysis panel is now available for clinical testing at the Spectrum Health Advanced Technology Laboratories (ATL). Continue Reading